Elia Sinaiko

620 total citations
11 papers, 488 citations indexed

About

Elia Sinaiko is a scholar working on Pharmacology, Physiology and Psychiatry and Mental health. According to data from OpenAlex, Elia Sinaiko has authored 11 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Pharmacology, 2 papers in Physiology and 2 papers in Psychiatry and Mental health. Recurrent topics in Elia Sinaiko's work include Dementia and Cognitive Impairment Research (2 papers), Treatment of Major Depression (2 papers) and Stress Responses and Cortisol (1 paper). Elia Sinaiko is often cited by papers focused on Dementia and Cognitive Impairment Research (2 papers), Treatment of Major Depression (2 papers) and Stress Responses and Cortisol (1 paper). Elia Sinaiko collaborates with scholars based in United States, United Kingdom and France. Elia Sinaiko's co-authors include ‌Barry Reisberg, Istvan Boksay, Stefanie Auer, Carol Torossian, Isabel Monteiro, Mony J. de Leon, Emile Franssen, Alan Kluger, Emma Shulman and Gertrude Steinberg and has published in prestigious journals such as American Journal of Psychiatry, Journal of Affective Disorders and Neurobiology of Aging.

In The Last Decade

Elia Sinaiko

11 papers receiving 455 citations

Peers

Elia Sinaiko

PMH

PHYSI

CN

GHP

BN

Kelly L. Davis United States

Karen Dahlman United States

Antonio Campayo Spain

Devangere Devanand United States

Claire Barkley United Kingdom

Ralph N. Wharton United States

Gail Gumbrecht United States

Gregory Swanwick Ireland

P Robert France

John A. Bokan United States

Kelly L. Davis United States

Elia Sinaiko

227 ×0.7

PMH

97 ×0.8

PHYSI

62 ×0.8

CN

48 ×1.0

GHP

71 ×1.5

BN

Citations per year, relative to Elia Sinaiko Elia Sinaiko (= 1×) peers Kelly L. Davis

Countries citing papers authored by Elia Sinaiko

Since Specialization

Citations

This map shows the geographic impact of Elia Sinaiko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elia Sinaiko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elia Sinaiko more than expected).

Fields of papers citing papers by Elia Sinaiko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elia Sinaiko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elia Sinaiko. The network helps show where Elia Sinaiko may publish in the future.

Co-authorship network of co-authors of Elia Sinaiko

This figure shows the co-authorship network connecting the top 25 collaborators of Elia Sinaiko. A scholar is included among the top collaborators of Elia Sinaiko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elia Sinaiko. Elia Sinaiko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Monteiro, Isabel, Istvan Boksay, Stefanie Auer, et al.. (1999). A FREQUENCY ADDENDUM TO THE BEHAVIORAL PATHOLOGY IN ALZHEIMER's DISEASE RATING SCALE (BEHAVE-AD). American Journal of Geriatric Psychiatry. 7. 51–51. 169 indexed citations

2.

Monteiro, Isabel, Istvan Boksay, Stefanie Auer, et al.. (1998). Reliability of Routine Clinical Instruments for the Assessment of Alzheimer's Disease Administered by Telephone. Journal of Geriatric Psychiatry and Neurology. 11(1). 18–24. 38 indexed citations

3.

Reisberg, ‌Barry, Emile Franssen, Stefanie Auer, et al.. (1996). Overview of Methodologie Issues for Pharmacologic Trials in Mild, Moderate, and Severe Alzheimer’s Disease. International Psychogeriatrics. 8(2). 159–193. 23 indexed citations

4.

Auer, Stefanie, et al.. (1996). 652 The treatment of behavioral symptoms in dementia: Haloperidol, thioridazine, and fluoxetine: A double-blind, placebo-controlled, eight month study. Neurobiology of Aging. 17(4). S162–S162. 4 indexed citations

5.

Santi, Susan De, Mony J. de Leon, Antonio Convit, et al.. (1995). Age-related changes in brain: II. Positron emission tomography of frontal and temporal lobe glucose metabolism in normal subjects. Psychiatric Quarterly. 66(4). 357–370. 64 indexed citations

6.

Franssen, Emile, et al.. (1991). Cognition-Independent Neurologic Symptoms in Normal Aging and Probable Alzheimer's Disease. Archives of Neurology. 48(2). 148–154. 60 indexed citations

7.

Reisberg, ‌Barry, Steven H. Ferris, Gertrude Steinberg, et al.. (1989). Longitudinal study of dementia patients and aged controls: An approach to methodologic issues.. 4 indexed citations

8.

Reisberg, ‌Barry, Steven H. Ferris, Emma Shulman, et al.. (1986). Longitudinal course of normal aging and progressive dementia of the Alzheimer's type: A prospective study of 106 subjects over a 3.6 year mean interval. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 10(3-5). 571–578. 61 indexed citations

9.

Georgotas, Anastasios, et al.. (1986). The relationship of the dexamethasone suppression test to subtypes of depression and to symptomatic severity in the elderly. Journal of Affective Disorders. 10(1). 51–57. 9 indexed citations

10.

Georgotas, Anastasios, Robert E. McCue, ‌Barry Reisberg, et al.. (1986). Dexamethasone suppression in dementia, depression, and normal aging. American Journal of Psychiatry. 143(4). 452–456. 53 indexed citations

11.

Young, Christopher, et al.. (1977). Alternative pasts: a study of weighted voting at the United Nations. International Organization. 31(3). 579–586. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact